期刊文献+

下肢动脉硬化闭塞症介入术后再狭窄的影响因素 被引量:3

Influencing Factors of Restenosis After Interventional Therapy in Lower Extremity Arteriosclerosis Obliterans
下载PDF
导出
摘要 目的分析下肢动脉硬化闭塞症患者经介入治疗后发生再狭窄的影响因素。方法将河南省人民医院血管外科于2019年10月至2021年10月收治的40例患有下肢动脉硬化闭塞症经介入治疗后随访6个月内发生再狭窄的患者作为发生组纳入,另将同期随访未发生再狭窄的46例患者作为未发生组纳入。在此基础上充分收集两组患者的一般资料,包括性别、年龄、体质量指数(BMI)、病变部位、糖尿病、高血压、长期吸烟、高脂血症以及Rutherford分级等。将两组患者的相关信息进行同质对比并分析影响下肢动脉硬化闭塞症患者经介入治疗后出现再狭窄的影响因素。结果两组患者在糖尿病、高血压、长期吸烟、高脂血症方面差异有统计学意义(P<0.05);另对比分析其他资料差异无统计学意义(P>0.05);后经logistic回归分析,糖尿病、高血压、长期吸烟、高脂血症是影响患者术后再狭窄发生的独立危险因素(OR>1,P<0.05)。结论介入术治疗下肢动脉硬化闭塞症的复发率受糖尿病、高血压、长期吸烟、高脂血症影响,故可针对性制定出完善的干预方案以降低其术后再狭窄的发生率。 Objective To analyze the influencing factors of restenosis in patients with lower extremity arteriosclerosis obliterans after interventional therapy.Methods A total of 40 patients with lower extremity arteriosclerosis obliterans who were treated in the Department of Vascular Surgery,Henan Provincial People’s Hospital from October 2019 to October 2021 and had restenosis within 6 months after interventional treatment were included as the occurrence group,and 46 patients who did not have restenosis in the follow-up results of the same period were included as the non occurrence group.On this basis,the general data of patients in both groups were fully collected,including gender,age,body mass index(BMI),lesion location,diabetes,hypertension,long-term smoking,hyperlipidemia and Rutherford classification.The relevant information of patients in the two groups was compared homogeneously and the influencing factors of restenosis in patients with lower extremity arteriosclerosis obliterans after interventional treatment were analyzed.Results Compared diabetes mellitus,hypertension,long-term smoking and hyperlipidemia of patients in both groups,the difference was statistically significant(P<0.05).There was no statistical significant difference in other data(P>0.05).Logistic regression analysis showed that diabetes mellitus,hypertension,long-term smoking and hyperlipidemia were independent risk factors for restenosis in patients after operation(OR>1,P<0.05).Conclusion The recurrence rate of interventional treatment of lower extremity arteriosclerosis obliterans is affected by diabetes mellitus,hypertension,long-term smoking and hyperlipidemia,so a perfect intervention plan can be formulated to reduce the incidence of postoperative restenosis.
作者 尉冠丽 王晓玉 史云霞 WEI Guanli;WANG Xiaoyu;SHI Yunxia(Department of Vascular Surgery,Henan Provincial People’s Hospital,Zhengzhou 450000,China)
出处 《河南医学研究》 CAS 2023年第2期268-271,共4页 Henan Medical Research
关键词 下肢动脉硬化闭塞症 再狭窄 糖尿病 高血压 长期吸烟 高脂血症 lower extremity arteriosclerosis obliterans restenosis diabetes mellitus hypertension long-term smoking hyperlipidemia
  • 相关文献

参考文献14

二级参考文献172

  • 1王磊,任昊,慈红波,戈小虎.影响下肢动脉硬化闭塞症腔内支架成形术后缺血症状复发的多因素分析[J].中国血管外科杂志(电子版),2014,6(4):226-229. 被引量:4
  • 2卢衡,郭平凡.血清肝素辅助因子Ⅱ活性与下肢动脉硬化闭塞症介入术后再狭窄相关[J].中南大学学报(医学版),2015,40(2):177-181. 被引量:15
  • 3陈维,章茂顺,胡春玲,唐丽萍,张建军.槲皮素及异鼠李素对人血管平滑肌细胞胶原合成的影响[J].中国动脉硬化杂志,2005,13(3):320-324. 被引量:7
  • 4程嘉艺,汤晴,杨金玲,近藤一直.沙棘总黄酮不同给药途径对血栓形成的影响[J].中成药,2006,28(2):262-264. 被引量:5
  • 5L. Norgren,W.R. Hiatt,J.A. Dormandy,M.R. Nehler,K.A. Harris,F.G.R. Fowkes.Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)[J]. Journal of Vascular Surgery . 2007 (1)
  • 6Florian Dick,Nicolas Diehm,Aekaterini Galimanis,Marc Husmann,Juerg Schmidli,Iris Baumgartner.Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome[J].Journal of Vascular Surgery.2007(4)
  • 7BessFowler,KonradJamrozik,PaulNorman,YvonneAllen.Prevalence of peripheral arterial disease: persistence of excess risk in former smokers[J].Australian and New Zealand Journal of Public Health.2007(3)
  • 8CAPRIE Steering Committee.A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). The Lancet . 1996
  • 9Alberico L. Catapano,?eljko Reiner,Guy De Backer,Ian Graham,Marja-Riitta Taskinen,Olov Wiklund,Stefan Agewall,Eduardo Alegria,M. John Chapman,Paul Durrington,Serap Erdine,Julian Halcox,Richard Hobbs,John Kjekshus,Pasquale Perrone Filardi,Gabriele Riccardi,Robert F. Storey,David Wood.??ESC/EAS Guidelines for the management of dyslipidaemias(J)Atherosclerosis . 2011 (1)
  • 10Yusuf S,Sleight P,Pogue J,Bosch J,Davies R,Dagenais G.Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. The New England Quarterly . 2000

共引文献412

同被引文献45

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部